Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Shares Issued: 2016-2024

Historic Shares Issued for Intellia Therapeutics (NTLA) over the last 9 years, with Dec 2024 value amounting to $5.9 million.

  • Intellia Therapeutics' Shares Issued rose 4.92% to $1.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year decrease of 33.10%. This contributed to the annual value of $5.9 million for FY2024, which is 11.17% down from last year.
  • As of FY2024, Intellia Therapeutics' Shares Issued stood at $5.9 million, which was down 11.17% from $6.6 million recorded in FY2023.
  • In the past 5 years, Intellia Therapeutics' Shares Issued registered a high of $400.0 million during FY2022, and its lowest value of $5.9 million during FY2024.
  • Moreover, its 3-year median value for Shares Issued was $6.6 million (2023), whereas its average is $137.5 million.
  • In the last 5 years, Intellia Therapeutics' Shares Issued soared by 873.38% in 2022 and then tumbled by 98.35% in 2023.
  • Intellia Therapeutics' Shares Issued (Yearly) stood at $11.6 million in 2020, then spiked by 255.05% to $41.1 million in 2021, then surged by 873.38% to $400.0 million in 2022, then plummeted by 98.35% to $6.6 million in 2023, then decreased by 11.17% to $5.9 million in 2024.